Cas:176637-98-2 methyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-(4-fluoroanilino)prop-2-enoate manufacturer & supplier

We serve Chemical Name:methyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-(4-fluoroanilino)prop-2-enoate CAS:176637-98-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-(4-fluoroanilino)prop-2-enoate

Chemical Name:methyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-(4-fluoroanilino)prop-2-enoate
CAS.NO:176637-98-2
Synonyms:Methyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-((4-fluorophenyl)amino)acrylate;2-[(2,4-dichloro-5-fluorophenyl)-oxomethyl]-3-(4-fluoroanilino)-2-propenoic acid methyl ester;2-(2,4-Dichloro-5-fluoro benzoyl)-3-(4′-fluoro-phenylamino)-acrylic methylester
Molecular Formula:C17H11Cl2F2NO3
Molecular Weight:386.17700
HS Code:2922499990

Physical and Chemical Properties:
Melting point:N/A
Boiling point:501.2ºC at 760 mmHg
Density:1.465g/cm3
Index of Refraction:1.605
PSA:55.40000
Exact Mass:385.00800
LogP:4.69630

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Methyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-((4-fluorophenyl)amino)acrylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2,4-Dichloro-5-fluoro benzoyl)-3-(4′-fluoro-phenylamino)-acrylic methylester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[(2,4-dichloro-5-fluorophenyl)-oxomethyl]-3-(4-fluoroanilino)-2-propenoic acid methyl ester Use and application,2-[(2,4-dichloro-5-fluorophenyl)-oxomethyl]-3-(4-fluoroanilino)-2-propenoic acid methyl ester technical grade,usp/ep/jp grade.


Related News: “Slower growth in China is no question,” AstraZeneca CEO Pascal Soriot told investors on the call. “We believe we can continue growing [and] maintain our position of leadership, but it’s going to be more difficult moving forward.” (7R,8R,9S,13S,14S,17S)-13-methyl-7-(5-(methyl(3-((4,4,5,5,5-pentafluoropentyl)sulfonyl)propyl)amino)pentyl)-3-((tetrahydro-2H-pyran-2-yl)oxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-ol manufacturers The government has approved a total of 33 applications with a committed investment of Rs 5,082.65 crore under the production linked incentive scheme for active pharmaceutical ingredients, an official release said on Thursday. methyl 4-bromo-5,5-dimethoxy-3,3-dimethylpentanoate suppliers In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. N-(2-(4-(2-fluoro-5-methoxybenzyl)piperidin-1-yl)ethyl)adamantane-1-carboxamide vendor & factory.